1-4 of 4
Isabelle Laverdiere
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Therapeutics That Can Target and Eradicate Leukemic Stem Cells in Acute Myeloid Leukemia: Investigating FDA-Approved Anti-Inflammatory Compounds

Isabella Iasenza, Meaghan Boileau, BSc, Andrea Neumann, BSc., Héloïse Frison, MSc., Mark D. Minden, MD PhD, Isabelle Laverdiere, BPharm, MSc, PhD, Kolja Eppert, MSc, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5052.
https://doi.org/10.1182/blood-2019-125338
Published: 2019
Journal Articles

Leukemic Stem Cell Expression Signatures Identify Novel Therapeutics for Acute Myeloid Leukemia

Meaghan Boileau, BSc, Isabelle Laverdiere, BPharm, MSc, PhD, Amanda Mitchell, PhD, Stanley W.K. Ng, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Kolja Eppert, MSc, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3815.
https://doi.org/10.1182/blood.V130.Suppl_1.3815.3815
Published: 2017
Journal Articles

Identification of Existing Bioactive Compounds That Target Acute Myeloid Leukemia Stem Cells

Isabelle Laverdiere, B.Pharm, PhD, Andrea L. Neumann, BSc, Meaghan Boileau, BSc, Heather Duncan, MSc, Sara Chisling, Amanda Mithchell, PhD, Stanley W.K. Ng, MSc, Jean C.Y. Wang, MDPhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Kolja Eppert, PhD
Journal: Blood
Blood (2015) 126 (23): 3681.
https://doi.org/10.1182/blood.V126.23.3681.3681
Published: 2015
Journal Articles

G Protein-Coupled Receptor 56 As a Potential Regulator of Normal and Leukemic Stem Cells

Heather Duncan, MSc, Karin G. Hermans, PhD, Sara Chisling, Isabelle Laverdiere, B.Pharm, PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Kolja Eppert, PhD
Journal: Blood
Blood (2015) 126 (23): 4267.
https://doi.org/10.1182/blood.V126.23.4267.4267
Published: 2015